8-K

$ABT · Abbott Laboratories

October 21, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

On October 21, 2026, Abbott Laboratories filed a current report on Form 8-K announcing that it plans to separate its global nutrition business into an independent, publicly traded company. The disclosure was made under Item 8.01, Other Events, and the announcement was included as Exhibit 99.1 in the form of a press release dated the same day.

The filing does not provide additional details about the structure, timing, or financial terms of the separation beyond the stated intention to create a standalone public company from the nutrition business. Abbott also noted that its common shares are registered on the New York Stock Exchange and NYSE Texas under the ticker symbol ABT.

The report was signed by Philip P. Boudreau, Executive Vice President, Finance and Chief Financial Officer. The attached press release is incorporated by reference into the filing.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →